Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Third-Party Inspections Hit Potential Legal Snag: Will MRA Save The Day?

This article was originally published in The Gray Sheet

Executive Summary

Proactive implementation of third-party inspections authorized by MDUFMA is needed to obtain a simpler version of the program through legislation, CDRH Director David Feigal said during a Nov. 21 AdvaMed seminar on the Medical Device User Fee & Modernization Act

You may also be interested in...



McClellan’s “Strong FDA” Is Unfazed By Device Appropriations Shortfall

FDA is assuring medical device execs that the Bush Administration is united in seeking the additional appropriations required by MDUFMA, but cannot guarantee that funding benchmarks will be met by 2004

McClellan’s “Strong FDA” Is Unfazed By Device Appropriations Shortfall

FDA is assuring medical device execs that the Bush Administration is united in seeking the additional appropriations required by MDUFMA, but cannot guarantee that funding benchmarks will be met by 2004

FDA MDUFMA Interpretation Stalls Third-Party Program At The Gate – NEMA

Third-party inspection standards outlined in an April 1FDA draft guidance on MDUFMA implementation could limit the ability of companies to hire EU-based third-party auditors, according to the National Electrical Manufacturers Association

Latest Headlines
See All
UsernamePublicRestriction

Register

MT017539

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel